International publisher IOS Press and the Editorial Board of the Journal of Alzheimers Disease (JAD) are proud to announce that the journal has achieved a 3.058 Impact Factor the first year that a rating has been assigned to this title. This is significantly higher than the only other journal devoted solely to Alzheimers disease (AD) research indexed in Thomson Scientifics Journal Citation Reports 2006.
Editors-in-Chief George Perry and Mark A. Smith commented, We are extremely pleased to have quantitative evidence of the high regard in which the Journal of Alzheimers Disease is held by researchers and clinicians working in AD and the extent to which JADs articles are cited throughout the medical and scientific literature. The dedication of the entire editorial board, contributing authors and our publisher, IOS Press, has certainly contributed to the success of the journal.
The Journal of Alzheimers Disease is one of our flagship publications, stated Einar Fredriksson, Director of IOS Press. As publisher, one of our primary goals is to provide an open forum for original research that will expedite the fundamental understanding of Alzheimer's disease. It is particularly gratifying to see the impact that this journal is having in the field. As the Journal of Alzheimers Disease continues to grow and flourish, future plans include increasing to 12 issues in 2008 and the inclusion of a Review Article section under the editorial guidance of Ralph N. Martins of the Edith Cowan University, Perth, Australia.